PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Fungal Pathogenesis Section, LCIM, NIAID, NIH, Bethesda, MD, United States.\', \'Immunopathogenesis Section, LCIM, NIAID, NIH, Bethesda, MD, United States.\', \'Human Immunological Diseases Section, LCIM, NIAID, NIH, Bethesda, MD, United States.\', \'National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD, United States.\', \'Immunology Service, Department of Laboratory Medicine, NIH Clinical Center, NIH, Bethesda, MD, United States.\', \'Immune Deficiency Genetics Section, LCIM, NIAID, NIH, Bethesda, MD, United States.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2021.720205
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34504497
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 Spike Protein-Directed Monoclonal Antibodies May Ameliorate COVID-19 Complications in APECED Patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34504497>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34504497>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all